PerpEquities

Equity · Healthcare

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) perpetual futures

HENGRUI perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade HENGRUIUSDT.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) tracked across crypto venues with normalized contract specifications.

$6.68-1.6%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · Gate.io (HENGRUI/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$0
Open interest
$17.1K
Best liquidity
$20.1
Gate.io
Tightest spread
+80.8 bps
Gate.io
Highest volume
$0
Gate.io
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $283.1M
OI / float
0.00%
Float $25.2B
Spot performance
1D-1.58%
5D+3.08%
1M-4.06%
6M-16.37%
YTD-24.69%
1Y-36.01%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Gate.ioTradeHENGRUI/USDTTrading$6.680.0% APR
0.000% every 8h
+80.8 bps$20.1$0$17.1KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

Too thin: Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

HENGRUI

Tightest spread

HENGRUI

Highest volume

HENGRUI

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 1h ago
Market cap
$42.6B
Updated 1h ago
Revenue
$4.7B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+24.7%
P/E
38.0
Peer P/E 19.7
Free cash flow
$846.1M
Trailing 12 months
More metrics
Net income
$1.1B
Trailing 12 months
P/S
9.1
Peer P/E
19.7
Similar listed perps
Revenue estimate
$5B
Next fiscal year
Earnings
2026-10-23
Revenue est. $1.4B · Updated 1h ago
Dividend
¥0.2
2026-05-27

Fundamental detail

Annual + quarterly
Latest revenue$4.7B
Net margin+24.5%
Free cash flow$1.2B
Net debt-$6B
2020$4.1B
2021$3.9B
2022$3.2B
2023$3.4B
2024$4.2B
2025$4.7B
PeriodRevenueGrowthNet incomeFCF
2020$4.1B+19%$941.4M$428M
2021$3.9B-7%$673.9M$379.9M
2022$3.2B-18%$581.1M-$108.1M
2023$3.4B+7%$640M$916.3M
2024$4.2B+23%$942.6M$811.2M
2025$4.7B+12%$1.1B$1.2B
PeriodGross marginOperating marginNet marginROEROA
2020+87.9%+25.3%+22.8%+20.7%+18.2%
2021+85.5%+18.0%+17.5%+12.9%+11.5%
2022+83.5%+19.3%+18.4%+10.3%+9.2%
2023+84.4%+21.5%+18.9%+10.6%+9.8%
2024+86.1%+26.8%+22.6%+13.9%+12.6%
2025+84.9%+25.5%+24.5%+12.6%+11.0%
PeriodCashDebtNet debtCurrent ratio
2020$1.6B$238.2M-$1.4B7.44
2021$2B$22.5M-$2B8.87
2022$2.2B$202.3M-$2B8.50
2023$3.1B$11.2M-$3.1B12.25
2024$3.7B$10.3M-$3.7B9.72
2025$6.1B$139.5M-$6B8.08
PeriodMarket capEnterprise valueP/SP/E
2020$87.8B$86.5B21.392.9
2021$48.1B$46.1B12.571.4
2022$36.5B$34.4B11.563.2
2023$42.6B$39.5B12.566.5
2024$43.3B$39.6B10.445.9
2025$57.6B$51.6B12.350.1
Q3 2024$980.1M
Q4 2024$1.2B
Q1 2025$1.1B
Q2 2025$1.3B
Q3 2025$1.1B
Q4 2025$1.3B
Q1 2026$1.2B
Q2 2026$1.1B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$980.1M+13%$176.7M$148.8M
Q4 2024$1.2B+34%$255.4M$355.9M
Q1 2025$1.1B+20%$278.8M-$21.8M
Q2 2025$1.3B+13%$383.2M$474.5M
Q3 2025$1.1B+13%$193.5M$649.2M
Q4 2025$1.3B+8%$291.5M$133.7M
Q1 2026$1.2B+13%$339.5M$12.2M
Q2 2026$1.1B-15%$324.7M$51M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+85.2%+20.6%+18.0%+2.7%+2.5%
Q4 2024+86.6%+27.5%+22.0%+3.8%+3.4%
Q1 2025+85.2%+28.9%+26.0%+4.0%+3.7%
Q2 2025+87.8%+35.9%+30.1%+4.4%+4.1%
Q3 2025+85.5%+17.3%+17.5%+2.2%+1.9%
Q4 2025+85.0%+25.0%+23.2%+3.2%+2.8%
Q1 2026+86.6%+30.7%+28.0%+3.6%+3.2%
Q2 2026+84.2%+21.8%+29.8%+3.4%+3.1%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$3.3B$7.6M-$3.3B9.00
Q4 2024$3.7B$10.3M-$3.7B9.72
Q1 2025$3.6B$9.3M-$3.6B10.70
Q2 2025$5.4B$82M-$5.4B13.49
Q3 2025$6B$12.3M-$6B6.55
Q4 2025$6.1B$139.5M-$6B8.08
Q1 2026$6B$10M-$6B9.23
Q2 2026$5.8B$107.6M-$5.7B11.68
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$49.4B$46.1B50.468.8
Q4 2024$43.3B$39.6B37.342.5
Q1 2025$45.7B$42.1B42.741.0
Q2 2025$49.1B$43.8B38.632.4
Q3 2025$70.3B$64.3B63.689.4
Q4 2025$58.6B$52.7B46.749.6
Q1 2026$54.2B$48.2B44.839.4
Q2 2026$51.1B$45.4B47.039.4

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$1.1BQ2 2026
$318.2M$636.3M$954.5M$1.3BQ3 2023: $869.5MQ4 2023: $863.7MQ1 2024: $892.1MQ2 2024: $1.1BQ3 2024: $980.1MQ4 2024: $1.2BQ1 2025: $1.1BQ2 2025: $1.3BQ3 2025: $1.1BQ4 2025: $1.3BQ1 2026: $1.2BQ2 2026: $1.1BQ3 2023Q2 2026
Net income$324.7MQ2 2026
$95.8M$191.6M$287.4M$383.2MQ3 2023: $173.4MQ4 2023: $123.3MQ1 2024: $203.6MQ2 2024: $306.8MQ3 2024: $176.7MQ4 2024: $255.4MQ1 2025: $278.8MQ2 2025: $383.2MQ3 2025: $193.5MQ4 2025: $291.5MQ1 2026: $339.5MQ2 2026: $324.7MQ3 2023Q2 2026
EBITDA$277.5MQ2 2026
$110.7M$221.3M$332M$442.7MQ3 2023: $207.9MQ4 2023: $106.7MQ1 2024: $244.6MQ2 2024: $324.7MQ3 2024: $235.1MQ4 2024: $259.9MQ1 2025: $328MQ2 2025: $442.7MQ3 2025: $240.4MQ4 2025: $377.5MQ1 2026: $380.4MQ2 2026: $277.5MQ3 2023Q2 2026
Free cash flow$51MQ2 2026
$145.9M$313.7M$481.4M$649.2MQ3 2023: $155.9MQ4 2023: $479.2MQ1 2024: $103.2MQ2 2024: $208.4MQ3 2024: $148.8MQ4 2024: $355.9MQ1 2025: -$21.8MQ2 2025: $474.5MQ3 2025: $649.2MQ4 2025: $133.7MQ1 2026: $12.2MQ2 2026: $51MQ3 2023Q2 2026
EPS$0.05Q2 2026
$0.01$0.03$0.04$0.06Q3 2023: $0.03Q4 2023: $0.02Q1 2024: $0.03Q2 2024: $0.05Q3 2024: $0.03Q4 2024: $0.04Q1 2025: $0.04Q2 2025: $0.06Q3 2025: $0.03Q4 2025: $0.04Q1 2026: $0.05Q2 2026: $0.05Q3 2023Q2 2026
Cash / Debt$5.8BQ2 2026
$1.5B$3B$4.6B$6.1BQ3 2023 · Cash: $2.6BQ3 2023 · Debt: $13.4MQ4 2023 · Cash: $3.1BQ4 2023 · Debt: $11.2MQ1 2024 · Cash: $3.2BQ1 2024 · Debt: $11.7MQ2 2024 · Cash: $3.3BQ2 2024 · Debt: $72.5MQ3 2024 · Cash: $3.3BQ3 2024 · Debt: $7.6MQ4 2024 · Cash: $3.7BQ4 2024 · Debt: $10.3MQ1 2025 · Cash: $3.6BQ1 2025 · Debt: $9.3MQ2 2025 · Cash: $5.4BQ2 2025 · Debt: $82MQ3 2025 · Cash: $6BQ3 2025 · Debt: $12.3MQ4 2025 · Cash: $6.1BQ4 2025 · Debt: $139.5MQ1 2026 · Cash: $6BQ1 2026 · Debt: $10MQ2 2026 · Cash: $5.8BQ2 2026 · Debt: $107.6MQ3 2023Q2 2026
CashDebt
Profitability+84.2%Q2 2026
+22.0%+44.0%+66.0%+88.0%Q3 2023 · Gross margin: +84.8%Q4 2023 · Gross margin: +84.4%Q1 2024 · Gross margin: +84.3%Q2 2024 · Gross margin: +88.0%Q3 2024 · Gross margin: +85.2%Q4 2024 · Gross margin: +86.6%Q1 2025 · Gross margin: +85.2%Q2 2025 · Gross margin: +87.8%Q3 2025 · Gross margin: +85.5%Q4 2025 · Gross margin: +85.0%Q1 2026 · Gross margin: +86.6%Q2 2026 · Gross margin: +84.2%Q3 2023 · Operating margin: +23.5%Q4 2023 · Operating margin: +16.7%Q1 2024 · Operating margin: +27.3%Q2 2024 · Operating margin: +30.9%Q3 2024 · Operating margin: +20.6%Q4 2024 · Operating margin: +27.5%Q1 2025 · Operating margin: +28.9%Q2 2025 · Operating margin: +35.9%Q3 2025 · Operating margin: +17.3%Q4 2025 · Operating margin: +25.0%Q1 2026 · Operating margin: +30.7%Q2 2026 · Operating margin: +21.8%Q3 2023 · Net margin: +19.9%Q4 2023 · Net margin: +14.3%Q1 2024 · Net margin: +22.8%Q2 2024 · Net margin: +27.1%Q3 2024 · Net margin: +18.0%Q4 2024 · Net margin: +22.0%Q1 2025 · Net margin: +26.0%Q2 2025 · Net margin: +30.1%Q3 2025 · Net margin: +17.5%Q4 2025 · Net margin: +23.2%Q1 2026 · Net margin: +28.0%Q2 2026 · Net margin: +29.8%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth-14.5%Q2 2026
-2.3%+9.9%+22.1%+34.3%Q3 2024: +12.7%Q4 2024: +34.3%Q1 2025: +20.1%Q2 2025: +12.5%Q3 2025: +12.7%Q4 2025: +8.3%Q1 2026: +13.0%Q2 2026: -14.5%Q3 2023Q2 2026
Shares outstanding6.6BQ2 2026
1.7B3.3B5B6.7BQ3 2023: 6.4BQ4 2023: 6.4BQ1 2024: 6.5BQ2 2024: 6.3BQ3 2024: 6.3BQ4 2024: 6.3BQ1 2025: 6.2BQ2 2025: 6.4BQ3 2025: 6.6BQ4 2025: 6.7BQ1 2026: 6.6BQ2 2026: 6.6BQ3 2023Q2 2026
Valuation39.4Q2 2026
22.444.767.189.4Q3 2023 · P/E: 62.4Q4 2023 · P/E: 87.0Q1 2024 · P/E: 55.1Q2 2024 · P/E: 29.9Q3 2024 · P/E: 68.8Q4 2024 · P/E: 42.5Q1 2025 · P/E: 41.0Q2 2025 · P/E: 32.4Q3 2025 · P/E: 89.4Q4 2025 · P/E: 49.6Q1 2026 · P/E: 39.4Q2 2026 · P/E: 39.4Q3 2023 · P/S: 48.9Q4 2023 · P/S: 49.5Q1 2024 · P/S: 50.3Q2 2024 · P/S: 32.0Q3 2024 · P/S: 50.4Q4 2024 · P/S: 37.3Q1 2025 · P/S: 42.7Q2 2025 · P/S: 38.6Q3 2025 · P/S: 63.6Q4 2025 · P/S: 46.7Q1 2026 · P/S: 44.8Q2 2026 · P/S: 47.0Q3 2023Q2 2026
P/EP/S
Revenue$4.7B2025
$1.2B$2.3B$3.5B$4.7B2018: $2.6B2019: $3.5B2020: $4.1B2021: $3.9B2022: $3.2B2023: $3.4B2024: $4.2B2025: $4.7B20182025
Net income$1.1B2025
$286.8M$573.5M$860.3M$1.1B2018: $604.8M2019: $792.5M2020: $941.4M2021: $673.9M2022: $581.1M2023: $640M2024: $942.6M2025: $1.1B20182025
EBITDA$1.4B2025
$359.4M$718.8M$1.1B$1.4B2018: $660.4M2019: $910.4M2020: $999.6M2021: $633.7M2022: $535.3M2023: $720.3M2024: $1.1B2025: $1.4B20182025
Free cash flow$1.2B2025
$228.5M$565.1M$901.7M$1.2B2018: $334M2019: $484.3M2020: $428M2021: $379.9M2022: -$108.1M2023: $916.3M2024: $811.2M2025: $1.2B20182025
EPS$0.182025
$0.04$0.09$0.13$0.182018: $0.092019: $0.122020: $0.152021: $0.112022: $0.092023: $0.12024: $0.152025: $0.1820182025
Cash / Debt$6.1B2025
$1.5B$3B$4.6B$6.1B2018 · Cash: $578.6M2018 · Debt: $97.4M2019 · Cash: $750.2M2019 · Debt: $62.5M2020 · Cash: $1.6B2020 · Debt: $238.2M2021 · Cash: $2B2021 · Debt: $22.5M2022 · Cash: $2.2B2022 · Debt: $202.3M2023 · Cash: $3.1B2023 · Debt: $11.2M2024 · Cash: $3.7B2024 · Debt: $10.3M2025 · Cash: $6.1B2025 · Debt: $139.5M20182025
CashDebt
Profitability+84.9%2025
+22.0%+43.9%+65.9%+87.9%2018 · Gross margin: +86.6%2019 · Gross margin: +87.5%2020 · Gross margin: +87.9%2021 · Gross margin: +85.5%2022 · Gross margin: +83.5%2023 · Gross margin: +84.4%2024 · Gross margin: +86.1%2025 · Gross margin: +84.9%2018 · Operating margin: +26.4%2019 · Operating margin: +26.4%2020 · Operating margin: +25.3%2021 · Operating margin: +18.0%2022 · Operating margin: +19.3%2023 · Operating margin: +21.5%2024 · Operating margin: +26.8%2025 · Operating margin: +25.5%2018 · Net margin: +23.3%2019 · Net margin: +22.9%2020 · Net margin: +22.8%2021 · Net margin: +17.5%2022 · Net margin: +18.4%2023 · Net margin: +18.9%2024 · Net margin: +22.6%2025 · Net margin: +24.5%20182025
Gross marginOperating marginNet margin
Revenue growth+12.3%2025
-5.0%+7.9%+20.8%+33.7%2019: +33.7%2020: +19.1%2021: -6.6%2022: -17.9%2023: +7.3%2024: +22.6%2025: +12.3%20182025
Shares outstanding6.5B2025
1.6B3.3B4.9B6.5B2018: 6.4B2019: 6.3B2020: 6.4B2021: 6.4B2022: 6.4B2023: 6.3B2024: 6.3B2025: 6.5B20182025
Valuation50.12025
23.246.469.792.92018 · P/E: 47.92019 · P/E: 72.42020 · P/E: 92.92021 · P/E: 71.42022 · P/E: 63.22023 · P/E: 66.52024 · P/E: 45.92025 · P/E: 50.12018 · P/S: 11.22019 · P/S: 16.52020 · P/S: 21.32021 · P/S: 12.52022 · P/S: 11.52023 · P/S: 12.52024 · P/S: 10.42025 · P/S: 12.320182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-23
Revenue est. $1.4B · Updated 1h ago
Dividend
¥0.2
2026-05-27

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20261.38$5B+7%11
FY 20271.54$5.7B+21%10
FY 20281.82$6.5B+39%14
FY 20292.88$8.9B+90%7
FY 20303.59$11B+135%11
Q2 20260.42$1.3B+2%3

Company events

6
2026-10-23EarningsActual - / Estimate 0.34-
2026-08-19EarningsActual 0.33 / Estimate 0.41Miss
2026-05-27Dividend¥0.2-
2026-04-22EarningsActual 0.34 / Estimate 0.33Beat
2026-03-25EarningsActual 0.31 / Estimate 0.34Miss
2025-10-23EarningsActual 0.2 / Estimate 0.3Miss

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering HENGRUI have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed
Avg. return after a rating (TipRanks)
Best / worst call / /

After buy calls on this stock: not enough measured cases yet

TipRanks data via FMP · computed Sep 24, 2026 · 0 ratings

Frequently asked questions

Where can I trade HENGRUI perpetual futures?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) perpetual futures trade on 1 crypto venues, including Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade HENGRUI around the clock?

Yes. Unlike the underlying stock, HENGRUI perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on HENGRUI perpetuals?

Right now the HENGRUI perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the HENGRUI perp price compare to the Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) stock?

The venue-median HENGRUI perp mark is $6.68 versus a reference stock price of $6.68, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a HENGRUI perpetual future?

A HENGRUI perpetual is a derivative that tracks the price of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) with no expiry date. It lets you take long or short exposure to Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) on crypto venues, around the clock.

What is HENGRUIUSDT perpetual?

HENGRUIUSDT is the symbol most crypto exchanges use for the Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) perpetual settled in USDT (Tether). It tracks the HENGRUI share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

HENGRUI perpetuals · perpequities.comHENGRUI perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/hengrui-perp"><img src="https://perpequities.com/badge/hengrui-perp.svg" width="240" height="64" alt="HENGRUI perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of HENGRUI perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for HENGRUI — one email every Sunday.

Watchlist and alerts

Price and funding alerts for HENGRUI, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X